Biotechnology News

November 19, 2012

LAGUNA BEACH, Calif.--(BUSINESS WIRE)--3V07 Healthcare Advertising Add Ian Koff as New Creative Director

November 19, 2012

NEW YORK--(BUSINESS WIRE)--On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1...

November 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in contrast to surveyed managed care organization (MCO) pharmacy directors’...

November 19, 2012

DUSSELDORF, Germany--(BUSINESS WIRE)--The Ministry of Industry and Trade of the Russian Federation led a united Russian delegation at the world’s largest medical trade fair MEDICA 2012 and presented the OPEN RUSSIA DAY. In the forthcoming years,...

November 19, 2012

CHICAGO--(BUSINESS WIRE)--Clontech has adopted SnapGene for cloning simulation and plasmid map drawing, and has endorsed SnapGene as the ideal partner for their In-Fusion cloning kits.

November 19, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at...

November 19, 2012

PARIS--(BUSINESS WIRE)--The 17th annual Longevity Prize of the Fondation Ipsen has been awarded to Linda Fried (Columbia University, New York, USA), in recognition of her outstanding leadership in the domain of the frailty syndrome, by an...

November 19, 2012

MADISON, Wis.--(BUSINESS WIRE)--BioForward announced today that Fritz Bittenbender, Vice President of Alliance Development and State Government Affairs for BIO

November 19, 2012

WASHINGTON--(BUSINESS WIRE)--A new 3-D “light switch” tool for could one day be used to treat conditions such as Parkinson’s and epilepsy by using gene therapy to turn individual brain cells on and off with light.

November 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The highest spending on Medical Science Liaisons (MSLs) occurs in the top markets, with $11.6 million spent on MSLs in the United States.

November 19, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low...

November 19, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Short R&D Timeline Could Lead to Larger Profits

November 19, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (Nasdaq: CGEN) announced today the signing of an agreement with a private U.S.-based investment company pursuant to which up to $15,000,000 in milestone related equity financing will be made...

November 19, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a...

November 19, 2012

SARATOGA, Calif.--(BUSINESS WIRE)--Peer-Reviewed Study in Nature Biotechnology Identifies New Pathway for Multiple Sclerosis Treatment

November 19, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Biotechnology company AGTC, which is developing gene therapy products to treat rare retinal diseases, has raised $37.5 million from three new investors.

November 19, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Exploring Strategic Alternatives to Maximize Growth and Shareholder Value

November 19, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27th at 1:30 p.m. (EST) in New York. The presentation will be webcast...

November 19, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

November 19, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coupons Make You Happier and More Relaxed, According to New Study by Claremont Graduate University

November 19, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen Announces Expanded Adoption of Argus® Whole Genome Mapping System

November 19, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--The National Football League (NFL) is moving from paper medical records to electronic and will utilize the eClinicalWorks comprehensive electronic health records (EHR) solution for this endeavor.

November 19, 2012

BOSTON--(BUSINESS WIRE)--Stealth Peptides Inc. reported today on Bendavia™ study findings presented during the annual American Society of Nephrology meeting

November 19, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions (NYSE:EBS) today announced that Robert G. Kramer has been appointed as the company’s chief financial officer effective December 3, 2012. Mr. Kramer succeeds R. Don Elsey, who will be leaving...

November 19, 2012

ARLINGTON, Tenn. & FRANKLIN, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) and BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that they have entered into a definitive agreement for a business combination of...

November 18, 2012

VIENNA--(BUSINESS WIRE)--Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been granted Chinese Patent No. CN101678040, entitled ‘Antiviral polymer’,...

November 17, 2012

WASHINGTON--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the positive Phase III AVAglio study. The study showed Avastin® (bevacizumab) in combination with radiation and...

November 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 12:00 p.m. EST...

November 16, 2012

DES MOINES, Iowa--(BUSINESS WIRE)--AgChoice applauds agriculture industry for the completion of part one of an industry Accord that will establish a framework for competition after biotechnology traits go off patent.

November 16, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn Announces Phase IIB Clinical Trial Agreement with Dr Jeffrey Jacobson, Drexel University College of Medicine for PRO 140, an experimental humanized monoclonal antibody for the treatment of HIV

November 16, 2012

WASHINGTON--(BUSINESS WIRE)--EPA’s logic-based decision to uphold the Renewable Fuel Standard will protect America’s energy security and maintain the industry’s progress in commercializing advanced biofuels

November 16, 2012

BOSTON--(BUSINESS WIRE)--OmniGuide, Inc. a leading developer of advanced microsurgical energy devices announced today that it was ranked in the Deloitte 2012 Technology Fast 500™. The list, which ranks the fastest growing technology companies by...

November 16, 2012

RIDGEFIELD, Conn.--(BUSINESS WIRE)--CoActiv Medical announces a broad range of introductions and enhancements to its EXAM-PACS®, EXAM-RIS® and cloud-based digital archiving family at the RSNA 2012 conference.

November 16, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 24th Annual Piper Jaffray Health Care Conference. The live presentation will occur...

November 16, 2012

--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by...

November 16, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc anounces publication of EGM Circular

November 16, 2012

FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--Gore announced the honorees of the 2011-2012 Pioneers in Performance Awards for the U.S. The award acknowledges exceptional work in the field of vascular and endovascular therapy.

November 16, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the quarter...

November 16, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN) announces that it has entered into a definitive agreement with SkinMedica, Inc. to acquire the privately held company’s topical aesthetics skin care business. Under the terms of the...

November 16, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) and its wholly owned subsidiary, ThoRx Laboratories, Inc., today confirm that they have initiated a challenge of the patents listed in the Orange Book in connection with...

November 16, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced top-line results of a double-blind, placebo-controlled, Phase 3 study evaluating both the 165 mg dose and the 330 mg dose of pregabalin controlled-release (CR) formulation in...

November 16, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and...

November 15, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will be presenting at the 24th Annual Piper Jaffray...

November 15, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex announces that across 3 Phase 2 studies of rindopepimut in EGFRvIII+ glioblastoma, survival data at the median and at 3-years suggest a substantial survival benefit vs independent controls.

November 15, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent for a $10 million...

November 15, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent (LOI) with Geron...

November 15, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the...